All Type of News
Green Cross stocks attracting investors on influenza A
As H1N1 influenza claimed the lives of three Koreans, shares of Green Cross Corp. have surged recently and the company’s total share values reached at 1.83 trillion won.
Indeed, Green Cross, the only Korean company...
Third death confirmed from influenza A
Korea’s third fatality is heightening flu fears further, putting the whole nation on full alert for the virus that is expected to gain strength in line with the onset of cooler weather in the months to come.
The 67...
Korean drugmakers facing ‘survival game’
From the local pharmaceutical companies to wholesalers, worries have arisen that the country might lose its leadership in the face of the government's plan to pass a bill aiming at introducing the controversial incent...
Korean scientists facilitates development of DNA-based medicine
Viromed Co. says it administered VM202RY, DNA-based medicine for ischemic disease including peripheral and coronary artery disease, to the last patient in the phase I, dose-escalation study for 9 Korean patients.
T...
20,000 Korean people could die from flu epidemic
The government expects the death toll from influenza A to reach 20,000 here in the worst-case scenario if it becomes an epidemic, thus raising people's concerns over the H1N1 flu virus.
According to data prepared j...
KFDA emphasizes safety of imported flu vaccine
The Korea Food and Drug Administration said that the drug agency will work out measures to reassure the public about the safety of i pandemic flu vaccines flu vaccines while revealing that the approval of imported flu...
Surgical masks, hand sanitizer in short supply
The rapid spread of the H1N1 flu virus has fanned public paranoia, prompting people to flock to buying liquid or gel hand sanitizer and surgical masks. Such frenzy is pushing mask or hand sensitizer producers scrambli...
Daewon to expand indications of felubiprofen
The Korea Food and Drug Administration gave its nod to the local clinical trials of Daewon’s felubiprofen (brandname: Peluvi), a nonsteroidal anti-inflammatory drug, aiming at expanding indications, such as lumbago.
...
Ahn named new marketing head of Roche Applied Science
Roche Diagnostics Korea has appointed Ahn Eun-uk, current managing director, as its new market chief of Applied Science business division.
Ahn holds a doctor degree after he majored in business administration at ...
Asbestos-containing drugs to be scrapped
The Korea Food and Drug Administration said on August 20 it will direct pharmaceutical companies, drugstores and hospitals to scrap about 1,000 drugs and medical goods that are confirmed to have used talc or talcum po...
